Provided by Tiger Trade Technology Pte. Ltd.

MBX Biosciences

58.51
+1.963.47%
Post-market: 58.510.00000.00%19:30 EDT
Volume:637.32K
Turnover:37.59M
Market Cap:2.82B
PE:-24.33
High:61.12
Open:59.28
Low:56.90
Close:56.55
52wk High:72.64
52wk Low:12.94
Shares:48.16M
Float Shares:27.63M
Volume Ratio:1.37
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4052
EPS(LYR):-2.3824
ROE:-33.17%
ROA:-22.08%
PB:6.88
PE(LYR):-24.56

Loading ...

Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss

MT Newswires Live
·
Aug 06

MBX Biosciences Posts Corporate Presentation on Precision Peptide Programs for Endocrine, Metabolic Diseases

Reuters
·
Aug 06

MBX Biosciences Q2 FY26 Net Loss Widens to $37.1 Million; R&D Expenses Rise to $31 Million

Reuters
·
Aug 06

MBX Biosciences Q2 EPS $(0.78) Misses $(0.63) Estimate

Benzinga Earnings
·
Aug 06

Press Release: MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights

Dow Jones
·
Aug 06

Mizuho Securities Sticks to Its Buy Rating for MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jul 29

MBX Biosciences price target raised to $90 from $60 at UBS

TIPRANKS
·
Jul 23

Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?

Simply Wall St.
·
Jul 18

MBX: Leadership Transition, Pipeline Visibility Support Maintained Buy Rating and Unchanged $91 Price Target

TIPRANKS
·
Jul 16

Analysts’ Top NA Picks: SanDisk Corp (SNDK), MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jul 16

Attovia Therapeutics Appoints John W. Smither to Board of Directors

THOMSON REUTERS
·
Jul 15

How MBX Biosciences’ New CEO-Chairman Structure Could Reframe the MBX Investment Narrative

Simply Wall St.
·
Jul 14

Wall Street Analysts Are Bullish on Top NA Picks

TIPRANKS
·
Jul 14

Stocks to Watch: Lulu's Fashion Lounge Holdings, MBX Biosciences, Rithm Property Trust

Dow Jones
·
Jul 14

MBX Biosciences Announces CEO Transition and Leadership Updates

TIPRANKS
·
Jul 14

MBX Biosciences Falls After Executive Shakeup

Reuters
·
Jul 14

MBX Biosciences Names Steve Hoerter CEO, Replacing Kent Hawryluk

Reuters
·
Jul 14

Mbx Biosciences - All Leadership Changes Effective Immediately

THOMSON REUTERS
·
Jul 14

Mbx Biosciences - Appoints Steve Hoerter as Chairman and CEO

THOMSON REUTERS
·
Jul 14

Mbx Biosciences - Kent Hawryluk Steps Down as President, CEO and Board Member

THOMSON REUTERS
·
Jul 14